

HY-145642 · 50 mg
MedChemExpress · Cat: HY-145642
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/masavibart.html
Description
Masavibart ZRC3308-A7 is an anti-SARS-CoV-2 monoclonal antibody IgG1 type . Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 HY-145643 at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease.







